Seres Therapeutics, Inc. (MCRB): Shareholders' Equity
$44.22M
As of 2025-12-31
$34.53M
As of 2026-06-30
+60.1%
3-year compound annual growth
-24.0%
5-year compound annual growth
-14.2%
10-year compound annual growth
| Period ended | Shareholders' Equity | Change YoY | Source filing |
|---|---|---|---|
| 2025-12-31 | $44.22M | +220.8% | 2026-03-12, Balance as of period end |
| 2024-12-31 | $13.78M | n/m | 2026-03-12, Balance as of period end |
| 2023-12-31 | -$44.86M | n/m | 2026-03-12, Balance as of period end |
| 2022-12-31 | $10.78M | -91.8% | 2025-03-13, Balance as of period end |
| 2021-12-31 | $131.51M | -24.7% | 2024-03-05, Balance as of period end |
| 2020-12-31 | $174.75M | n/m | 2023-03-07, Balance as of period end |
| 2019-12-31 | -$48.32M | n/m | 2022-03-01, Balance as of period end |
| 2018-12-31 | -$48.05M | n/m | 2021-03-02, Balance as of period end |
| 2017-12-31 | $60.70M | -54.2% | 2020-03-02, Balance as of period end |
| 2016-12-31 | $132.63M | -35.4% | 2019-03-06, Balance as of period end |
| 2015-12-31 | $205.39M | n/m | 2018-03-08, Balance as of period end |
| 2014-12-31 | -$26.72M | n/m | 2017-03-16, Balance as of period end |
| 2013-12-31 | -$11.12M | n/a | 2016-03-14, Balance as of period end |
Shareholders' Equity at similar companies
| Company | Year ended | Shareholders' Equity | Change YoY |
|---|---|---|---|
| Seres Therapeutics, Inc. (MCRB) | 2025-12-31 | $44.22M | +220.8% |
| Elite Pharmaceuticals Inc (ELTP) | 2026-03-31 | $98.88M | +84.8% |
| Monopar Therapeutics (MNPR) | 2025-12-31 | $137.83M | +150.4% |
| Prelude Therapeutics Inc (PRLD) | 2025-12-31 | $68.64M | -47.8% |
| Silence Therapeutics plc (SLN) | 2025-12-31 | $62.30M | -53.5% |
| Larimar Therapeutics, Inc. (LRMR) | 2025-12-31 | $78.08M | -54.6% |
| Citius Pharmaceuticals, Inc. (CTXR) | 2025-09-30 | $67.55M | -3.6% |
| Acrivon Therapeutics, Inc. (ACRV) | 2025-12-31 | $112.52M | -36.4% |
| XBiotech Inc. (XBIT) | 2025-12-31 | $140.35M | -23.0% |
Compare MCRB, ELTP, MNPR, PRLD side by side · Screen every company in Pharmaceutical Preparations ↗